A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2001
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001	EP1163267A1 47 human secreted proteins
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163256A1 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163243A2 Calanolides for inhibiting btk
12/19/2001	EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/19/2001	EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001	EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001	EP1163228A1 Quinazolines and therapeutic use thereof
12/19/2001	EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
12/19/2001	EP1163219A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
12/19/2001	EP1163214A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001	EP1163208A2 Caspase inhibitors and uses thereof
12/19/2001	EP1163008A1 Use of trehalose for stabilising a liquid vaccine
12/19/2001	EP1163003A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
12/19/2001	EP1163002A2 Polycationic carbohydrates as immunostimulants in vaccines
12/19/2001	EP1163001A2 Vaccine composition
12/19/2001	EP1163000A2 Vaccine against antigens from bacteriae
12/19/2001	EP1162999A2 Vaccine against Streptococcus pneumoniae
12/19/2001	EP1162998A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
12/19/2001	EP1162996A2 Hapten-conjugated mammalian cells and methods of making and using thereof
12/19/2001	EP1162974A1 Quinazoline formulations and therapeutic use thereof
12/19/2001	EP1162970A2 Anti-inflammatory uses of manzamines
12/19/2001	EP1162953A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
12/19/2001	EP1162945A1 Particle based vaccine composition
12/19/2001	EP1162875A2 Plants transformed with thioredoxin
12/19/2001	EP1001990A4 Protein that binds trail
12/19/2001	EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof
12/19/2001	EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives
12/19/2001	EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
12/19/2001	EP0758387B1 Thymidine kinase mutants
12/19/2001	EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors
12/19/2001	EP0535021B1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
12/19/2001	CN1327388A Modified antibodies of induced anti-idiotype reaction enhancement
12/19/2001	CN1327065A New polypeptide-human biphenyl hydrolase-relative protein (Bph-rp) 16.06 and polynucleotide for encoding such polypeptide
12/19/2001	CN1326982A New polypeptide-pogo transposon 18 and polynucleotide for encoding such polypeptide
12/19/2001	CN1326947A Human thymosin alpha protogene mutant synthesis, expression and use
12/19/2001	CN1326776A Rhodiola root medicinal tea
12/19/2001	CN1326743A Process for preparing 1,3-oxygen-sulphur cyclopentane nucleotide like medicine composition
12/19/2001	CN1076204C Recombinant coccidiosis vaccines
12/19/2001	CA2350857A1 The use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease
12/18/2001	US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001	US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration
12/18/2001	US6331560 Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals
12/18/2001	US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors
12/18/2001	US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001	US6331539 Sulfonamide and sulfamide substituted imidazoquinolines
12/18/2001	US6331433 Human T cell leukemia cell line designated D1.1
12/18/2001	CA2202484C Use of indole derivatives for the treatment of various diseases
12/18/2001	CA2057917C New class of compounds having a variable spectrum of activities for capsaicin-like responses, compositions and uses thereof
12/18/2001	CA2031897C Carbamoyl derivatives
12/13/2001	WO2001094612A2 Method for identifying medically valuable active substances
12/13/2001	WO2001094586A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
12/13/2001	WO2001094585A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
12/13/2001	WO2001094582A1 Novel g protein-coupled receptor protein and dna thereof
12/13/2001	WO2001094568A1 A NEW POLYPEPTIDE- HUMAN II CLASS AMINOACYL-tRNA SYNTHETASE 10 AND THE POLYNUCLEOTIDE ENCODING IT
12/13/2001	WO2001094567A1 A new polypeptide- human sailor transposase 11 and the polynucleotide encoding it
12/13/2001	WO2001094555A1 Method for obtaining characterised muscle-derived cell populations and uses
12/13/2001	WO2001094551A2 Genetically modified t-cells, method for producing them and use thereof
12/13/2001	WO2001094529A2 A novel polypeptide, a human atp dependant serine proteinase 21 and the polynucleotide encoding the polypeptide
12/13/2001	WO2001094419A2 Method to induce the th1 immune response
12/13/2001	WO2001094415A2 Nuclear hormone receptor
12/13/2001	WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
12/13/2001	WO2001094404A1 A new polypeptide- human l1 retroposon 22 and the polynucleotide encoding it
12/13/2001	WO2001094403A1 A new polypeptide- human transcriptional activation subunit 14 and the polynucleotide encoding it
12/13/2001	WO2001094402A1 A new polypeptide---human npat protein 12 and the polynucleotide encoding it
12/13/2001	WO2001094401A1 A new polypeptide-human npat protein 15 and the polynucleotide encoding it
12/13/2001	WO2001094391A2 Intracellular signaling proteins
12/13/2001	WO2001094368A1 2-aminocarbonyl-9h-purine derivatives
12/13/2001	WO2001094351A1 Caspase inhibitors and uses thereof
12/13/2001	WO2001094350A1 6-phenylpyrrolopyrimidinedione derivatives
12/13/2001	WO2001094347A1 Tetracyclic diketopiperazine compounds as pdev inhibitors
12/13/2001	WO2001094346A1 1,3,8-TRIAZA-SPIRO'4,5&excl;DECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS
12/13/2001	WO2001094345A2 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
12/13/2001	WO2001094326A1 Novel thiazolidinedione derivatives and use thereof as drugs
12/13/2001	WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
12/13/2001	WO2001094312A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
12/13/2001	WO2001093921A2 Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
12/13/2001	WO2001093913A2 T cell receptor fusions and conjugates and methods of use thereof
12/13/2001	WO2001093912A1 Vaccine
12/13/2001	WO2001093907A1 Chair
12/13/2001	WO2001093906A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form
12/13/2001	WO2001093905A1 Immunostimulatory oligodeoxynucleotides
12/13/2001	WO2001093903A1 Antigenic composition comprising a polycationic peptide and inosine and cytosine
12/13/2001	WO2001093902A2 Immunostimulatory rna/dna hybrid molecules
12/13/2001	WO2001093885A1 Therapeutic agents - ii
12/13/2001	WO2001093884A1 Therapeutic agents - i
12/13/2001	WO2001093883A1 Therapeutic agents - iii
12/13/2001	WO2001093881A1 Immunological substance containing enteroabsorbable anti-inflammatory factor and application thereof
12/13/2001	WO2001093836A2 Encapsulation of polynucleotides and drugs into targeted liposomes
12/13/2001	WO2001044445A3 Human lyases and associated proteins
12/13/2001	WO2001044200A3 Selective neurokinin antagonists
12/13/2001	WO2001043694A3 Compositions and methods for caspase-induced apoptosis
12/13/2001	WO2001039800A3 Controlled delivery of antigens
12/13/2001	WO2001037820A3 Ionizable indolinone derivatives and their use as ptk ligands
12/13/2001	WO2001027245A3 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells

1 ... 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 ... 1172